In 2022, a study revealed that about 800 papers published in crystallography and exotic-chemistry journals originated from a paper mill. At the time, popular scientific sleuth David Bimler noted in ...

Drug repurposing, the application of an existing therapeutic to a new disease indication, holds promise of rapid clinical impact at a lower cost than de novo drug development. So far, there has not ...

DeepMind is partnering with EMBL to make the most complete and accurate database yet of the predicted human protein structures freely and openly available to the scientific community. The AlphaFold ...